XACT Robotics
Israel - CaesareaBiotechnology
Focus: XACT Robotics develops robotic systems for CT-guided minimally invasive percutaneous procedures including biopsies and tumor interventions. The company is an early-stage Israeli medtech startup founded in 2022 with a narrow, specialized focus on procedural robotics.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About XACT Robotics
AI assessmentNot HiringNo open roles listed right now. Follow XACT Robotics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
XACT Robotic System
CT-guided Minimally Invasive Procedures e.g., BiopsiesClinical Trials (1)
NCT03008603Evaluation of the Safety, Effectiveness & Usability of the XACT Robotic System for Image Guided Percutaneous Procedures
N/AHelp build intelligence for XACT Robotics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.